N-(4-Phenyl-1,2,3,4-tetrahydronaphthalen-2-yl)propionamide N-(4-苯基-1,2,3,4-四氢萘-2-基)丙酰胺
CAS 134865-74-0 MFCD00901545
化学结构图
SMILES: CCC(=O)NC1CC2C=CC=CC=2C(C1)C1C=CC=CC=1
化学属性
| Mol. Formula | C19H21NO |
|---|---|
| Mol. Weight | 279.38 |
| Melting Point | 164.0 to 168.0 deg-C |
别名和识别编码
| Chemical Name | N-(4-Phenyl-1,2,3,4-tetrahydronaphthalen-2-yl)propionamide |
|---|---|
| Reaxys-RN | 8627599 |
| Chemical Name Translation | N-(4-苯基-1,2,3,4-四氢萘-2-基)丙酰胺 |
| MDL Number | MFCD00901545 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. hin EJ, et al. Melatonin attenuates memory impairment induced by Klotho gene deficiency via interactive signaling between MT2 receptor, ERK, and Nrf2-related antioxidant potential. Int J Neuropsychopharmacol. 2014 Dec 30;18(6). pii: pyu105.
- [3]. Christopher Browning, et al. Pharmacological characterization of human recombinant melatonin mt1 and MT2 receptors. British Journal of Pharmacology (2000) 129, 877-886.
- [4]. Dubocovich ML, et al. Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn Schmiedebergs Arch Pharmacol. 1997 Mar;355(3):365-75.
- [5]. Roberto Pariente, et al. Participation of MT3 melatonin receptors in the synergistic effect of melatonin on cytotoxic and apoptotic actions evoked by chemotherapeutics. Cancer Chemother Pharmacol. 2017 Nov;80(5):985-998.
- [1]. Dubocovich
